Juniper, formerly known as Climate Capital Bio is a Pre-Seed venture fund backing biotech climate solutions that allow the decarbonization of the world’s largest and least sustainable industries. The fund is 50% closed, 30% deployed, and has four markups. Led by founders-turned investors Jenny Kan and Michael Luciani, the fund is built on Jenny’s expertise as lead engineer in a Nobel Laureate’s synthetic biology lab, Michael’s deal flow network from building the Climate Capital Syndicate into one of the world’s most active climate investors, and their track record leading 30 biotech x climate investments together - currently marked up 4.0x.